Published in Diabet Med on April 07, 2015
Can a simple test of functional capacity add to the clinical assessment of diabetes? Diabet Med (2015) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Index for rating diagnostic tests. Cancer (1950) 27.09
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07
Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 15.48
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (2010) 9.20
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Diagnostic tests 4: likelihood ratios. BMJ (2004) 7.33
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology (2005) 4.65
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care (2003) 3.18
An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia (2004) 2.41
Screening for type 2 diabetes. Diabetes Care (2003) 1.89
Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart (2011) 1.60
Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract (2008) 1.57
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52
Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care (1984) 1.48
Automated standardized pupillometry with optical method for purposes of clinical practice and research. Clin Physiol (2000) 1.37
Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care (2002) 1.29
Validation of the Omron M7 (HEM-780-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit (2008) 1.19
Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study. Biomed Eng Online (2010) 1.17
QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab (1987) 1.16
Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med (1998) 1.13
The association between socioeconomic status and obesity in Peruvian women. Obesity (Silver Spring) (2011) 1.04
Validation of the OMRON M7 (HEM-780-E) blood pressure measuring device in a population requiring large cuff use according to the International Protocol of the European Society of Hypertension. Blood Press Monit (2007) 0.94
The "rule of halves" does not apply in Peru: awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants. Crit Pathw Cardiol (2013) 0.94
Cardiovascular risk awareness, treatment, and control in urban Latin America. Am J Ther (2010) 0.93
Cardiovascular autonomic neuropathy: diagnosis and management. Curr Diab Rep (2006) 0.91
Dynamic pupillometry as an autonomic testing tool. Clin Auton Res (2013) 0.85
Prediction of sudden cardiac death in diabetic autonomic neuropathy. J Nucl Med (1988) 0.83
An approach to the assessment of diabetic neuropathy based on dynamic pupillometry. Conf Proc IEEE Eng Med Biol Soc (2007) 0.82
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52
A cross-sectional study of determinants of indoor environmental exposures in households with and without chronic exposure to biomass fuel smoke. Environ Health (2014) 1.05
Chronic exposure to biomass fuel is associated with increased carotid artery intima-media thickness and a higher prevalence of atherosclerotic plaque. Heart (2013) 1.01
Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res (2015) 0.89
Impact of urbanisation and altitude on the incidence of, and risk factors for, hypertension. Heart (2017) 0.83
Contribution of modifiable risk factors for hypertension and type-2 diabetes in Peruvian resource-limited settings. J Epidemiol Community Health (2015) 0.82
Sleep Disordered Breathing in Four Resource-Limited Settings in Peru: Prevalence, Risk Factors, and Association with Chronic Diseases. Sleep (2015) 0.82
Obesity risk in rural, urban and rural-to-urban migrants: prospective results of the PERU MIGRANT study. Int J Obes (Lond) (2015) 0.81
Urbanisation but not biomass fuel smoke exposure is associated with asthma prevalence in four resource-limited settings. Thorax (2015) 0.80
Lack of association between chronic exposure to biomass fuel smoke and markers of right ventricular pressure overload at high altitude. Am Heart J (2014) 0.80
Burden of chronic kidney disease in resource-limited settings from Peru: a population-based study. BMC Nephrol (2015) 0.79
Distribution of Short-Term and Lifetime Predicted Risks of Cardiovascular Diseases in Peruvian Adults. J Am Heart Assoc (2015) 0.79
Migration, urbanisation and mortality: 5-year longitudinal analysis of the PERU MIGRANT study. J Epidemiol Community Health (2015) 0.79
Spatial distribution of individuals with symptoms of depression in a periurban area in Lima: an example from Peru. Ann Epidemiol (2015) 0.79
A cross-sectional study of differences in 6-min walk distance in healthy adults residing at high altitude versus sea level. Extrem Physiol Med (2014) 0.78
Geographical variation in the progression of type 2 diabetes in Peru: The CRONICAS Cohort Study. Diabetes Res Clin Pract (2016) 0.78
Chronic exposure to biomass fuel smoke and markers of endothelial inflammation. Indoor Air (2015) 0.76
Glycated haemoglobin (HbA1c ) and fasting plasma glucose relationships in sea-level and high-altitude settings. Diabet Med (2017) 0.75
Can a simple test of functional capacity add to the clinical assessment of diabetes? Diabet Med (2015) 0.75
Depressive Mood Among Within-Country Migrants in Periurban Shantytowns of Lima, Peru. J Immigr Minor Health (2015) 0.75
Characteristics Associated With Antihypertensive Treatment and Blood Pressure Control: A Population-Based Follow-Up Study in Peru. Glob Heart (2016) 0.75
Nutrition status of children in Latin America. Obes Rev (2017) 0.75
Role of mHealth in overcoming the occurrence of post-stroke depression. Acta Neurol Scand (2017) 0.75
Urbanization, mainly rurality, but not altitude is associated with dyslipidemia profiles. J Clin Lipidol (2017) 0.75
A research agenda to guide progress on childhood obesity prevention in Latin America. Obes Rev (2017) 0.75
Risk score for first-screening of prevalent undiagnosed chronic kidney disease in Peru: the CRONICAS-CKD risk score. BMC Nephrol (2017) 0.75
Delivery of Type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru. Diabet Med (2016) 0.75
Cardiometabolic correlates of sleep disordered breathing in Andean highlanders. Eur Respir J (2017) 0.75
Biomass fuel smoke exposure was associated with adverse cardiac remodeling and left ventricular dysfunction in Peru. Indoor Air (2016) 0.75